Marijuana Company of America, Inc. (MCOA) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Marijuana Company of America, Inc. (MCOA) trades at $0.0001 with AI Score 42/100 (Grade C). Marijuana Company of America, Inc. develops and distributes cannabis and CBD products under the hempSMART brand. Market cap: $2.21M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for MCOA: MCOA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MCOA against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MCOA: 2/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Marijuana Company of America, Inc. (MCOA) Healthcare & Pipeline Overview
Marijuana Company of America, Inc. focuses on developing and distributing cannabis and CBD products under the hempSMART brand, targeting the wellness market through online and affiliate channels, while facing significant challenges in profitability and market competition within the specialty drug manufacturing sector.
What Is the Investment Thesis for MCOA?
Investing in Marijuana Company of America, Inc. presents significant risks due to its negative profitability and high beta of 9.91, indicating extreme volatility relative to the market. The company's negative profit margin of -1441.1% and gross margin of -74.1% raise concerns about its financial sustainability. Growth depends on successful expansion of the hempSMART product line and effective marketing strategies to increase sales through online and affiliate channels. Potential investors should carefully consider the risks associated with OTC-listed companies and the competitive landscape of the cannabis and CBD market. The company's small size, with only 7 employees, also poses operational challenges.
Based on FMP financials and quantitative analysis
MCOA Key Highlights
Market capitalization of $2.21M indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.09 reflects negative earnings and challenges in achieving profitability.
- Profit margin of -1441.1% highlights significant losses and operational inefficiencies.
- Gross margin of -74.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's business model.
- Beta of 9.91 suggests extreme volatility compared to the broader market, making it a high-risk investment.
Who Are MCOA's Competitors?
MCOA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MCOA's Key Strengths?
Established hempSMART brand.
- Proprietary formulations like hempSMART Brain.
- Distribution network through cdistro.com.
- Direct-to-consumer sales channel.
What Are MCOA's Weaknesses?
Negative profitability and gross margins.
- High beta indicating extreme volatility.
- Limited financial resources.
- Small employee base.
What Could Drive MCOA Stock Higher?
MCOA catalyst: Potential legalization of cannabis at the federal level in the U.S., which could significantly expand the market for MCOA's products.
- Expansion of the hempSMART product line to include new formulations and delivery methods.
- Strategic partnerships and distribution agreements to increase market reach.
- Enhanced e-commerce and digital marketing efforts to drive online sales.
- International expansion into legal cannabis markets.
What Are the Key Risks for MCOA?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis and CBD market, which could erode MCOA's market share.
- Complex and evolving regulatory landscape, which could impact MCOA's ability to operate and sell its products.
- Fluctuations in consumer demand for cannabis and CBD products.
- Potential for product recalls or safety concerns, which could damage MCOA's brand reputation.
- Negative profitability and gross margins, which could threaten MCOA's financial sustainability.
What Are the Growth Opportunities for MCOA?
- Expansion of hempSMART Product Line: MCOA has the opportunity to expand its hempSMART product line to cater to a broader range of consumer needs. By introducing new formulations and delivery methods, such as edibles or topicals, MCOA can attract new customers and increase sales. The global CBD market is projected to reach $16 billion by 2028, providing a substantial market opportunity for MCOA to capitalize on. This expansion requires investment in research and development and effective marketing strategies.
- Strategic Partnerships and Distribution Agreements: MCOA can pursue strategic partnerships and distribution agreements to expand its reach and access new markets. Collaborating with established retailers or distributors can provide MCOA with access to a wider customer base and increase brand awareness. The company can also explore partnerships with healthcare providers or wellness centers to promote its products. These partnerships can be established within the next 1-2 years, driving revenue growth and market penetration.
- International Expansion: MCOA can explore international expansion opportunities in countries where cannabis and CBD products are legal. By entering new markets, MCOA can diversify its revenue streams and reduce its reliance on the U.S. market. The European CBD market, for example, is experiencing rapid growth, presenting a significant opportunity for MCOA. This expansion will require careful consideration of regulatory requirements and market dynamics in each country.
- Focus on E-commerce and Digital Marketing: MCOA can enhance its e-commerce platform and digital marketing efforts to drive online sales. By optimizing its website for search engines and investing in targeted advertising campaigns, MCOA can attract more customers and increase conversion rates. The company can also leverage social media platforms to engage with customers and build brand awareness. These digital strategies can be implemented within the next 6-12 months, leading to increased online sales and customer engagement.
- Development of Proprietary Formulations and Intellectual Property: MCOA can invest in research and development to create proprietary formulations and intellectual property for its products. By developing unique and differentiated products, MCOA can establish a competitive advantage and protect its market share. The company can also seek patents for its formulations and technologies, further strengthening its intellectual property portfolio. This long-term strategy can enhance MCOA's brand reputation and attract investors.
What Are MCOA's Competitive Advantages?
- Brand recognition of hempSMART products.
- Proprietary formulations, including hempSMART Brain.
- Established distribution network through cdistro.com.
- Affiliate marketing program driving sales.
What Does MCOA Do?
Marijuana Company of America, Inc. (MCOA) was founded in 1985 as Converge Global, Inc., before rebranding in December 2015 to capitalize on the emerging cannabis and CBD market. The company develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand within the United States. MCOA's product line includes hempSMART Brain, a patented personal care product for brain wellness; hempSMART Pain capsules and cream for discomfort relief; hempSMART Drops, a hemp CBD oil tincture; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, a powderized CBD drink. These products are primarily sold through the company's website and affiliate marketing programs. Additionally, MCOA distributes hemp and CBD products, including smoke and vape shop related items, to wholesalers, c-stores, specialty retailers, and consumers through its cdistro.com platform. Headquartered in Los Angeles, California, MCOA aims to establish a presence in the growing CBD and cannabis wellness market.
What Products and Services Does MCOA Offer?
- Develops and produces cannabis and cannabidiol (CBD) products.
- Distributes products under the hempSMART brand.
- Offers hempSMART Brain for brain wellness.
- Provides hempSMART Pain capsules and cream for discomfort relief.
- Sells hempSMART Drops, a hemp CBD oil tincture.
- Markets hempSMART Pet Drops for cats and dogs.
- Offers hempSMART Face, a facial moisturizer.
- Distributes hemp and CBD products through www.cdistro.com.
How Does MCOA Make Money?
- Develops and manufactures hempSMART branded CBD and cannabis products.
- Sells products directly to consumers through its website.
- Distributes products through affiliate marketing programs.
- Wholesales hemp and CBD products to retailers via cdistro.com.
What Industry Does MCOA Operate In?
Marijuana Company of America, Inc. operates in the rapidly evolving cannabis and CBD market, which is characterized by increasing consumer demand for wellness products. The industry is highly competitive, with numerous companies vying for market share. MCOA faces competition from established players and emerging brands. The regulatory landscape is complex and varies by state, creating both opportunities and challenges for companies in this sector. The global cannabis market is projected to reach significant growth in the coming years, driven by increasing legalization and acceptance of cannabis and CBD products.
Who Are MCOA's Key Customers?
- Individual consumers seeking wellness and pain relief products.
- Retailers, including smoke shops, vape shops, and c-stores.
- Wholesalers distributing hemp and CBD products.
- Affiliate marketers promoting hempSMART products.
Company Profile
Marijuana Company of America, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Los Angeles, US. The company is led by CEO Jesus Quintero. MCOA has traded publicly since 1999.
How Marijuana Company of America, Inc. Is Valued
Marijuana Company of America, Inc. carries a market capitalization of $2.21M, placing it in the micro-cap category. Relative to its peer group, MCOA's quantitative score of 42/100 is below the peer average of 62/100.
Key Financial Metrics
Return on equity for Marijuana Company of America, Inc. stands at 328.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Marijuana Company of America, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
MCOA Financials
Bull Case vs Bear Case
Bull Case
- Established hempSMART brand.
- Proprietary formulations like hempSMART Brain.
- Distribution network through cdistro.com.
- Direct-to-consumer sales channel.
Bear Case
- Negative profitability and gross margins.
- High beta indicating extreme volatility.
- Limited financial resources.
- Small employee base.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
MCOA Latest News
No recent news available for MCOA.
MCOA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MCOA.
Price Targets
Wall Street price target analysis for MCOA.
MCOA MoonshotScore
What does this score mean?
The MoonshotScore rates MCOA 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Jesus Quintero
CEO
Jesus Quintero serves as the CEO of Marijuana Company of America, Inc. His background includes experience in managing and developing businesses, with a focus on the cannabis and CBD industry. He has been instrumental in guiding the company's strategic direction and product development efforts. His expertise lies in identifying market opportunities and building partnerships to expand the company's reach. He is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Track Record: Under Jesus Quintero's leadership, Marijuana Company of America, Inc. has focused on expanding its hempSMART product line and establishing a presence in the competitive CBD market. Key milestones include the development of hempSMART Brain and the expansion of the company's online sales channels. He has also focused on building relationships with affiliate marketers to drive sales and increase brand awareness. His tenure has been marked by efforts to navigate the evolving regulatory landscape and position the company for growth.
MCOA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Company of America, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility. This tier is often populated by shell companies, companies in distress, or those with minimal operations.
- OTC Tier: OTC Other
- Limited financial disclosure and potential for lack of transparency.
- Low trading volume and illiquidity.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Potential for delisting or suspension of trading.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established hempSMART brand.
- Online presence and direct-to-consumer sales channel.
- Distribution network through cdistro.com.
- Management team in place.
Common Questions About MCOA (Healthcare)
What does the AI Score mean for MCOA?
MCOA holds an AI Score of 42/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Marijuana Company of America, Inc. develops and distributes cannabis and CBD products under the hempSMART brand. The company targets the wellness market with a range of products available through …
What does Marijuana Company of America, Inc. do?
Marijuana Company of America, Inc. (MCOA) develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand. The company's product line includes personal care products, pain relief capsules and creams, CBD oil tinctures, pet products, and drink mixes. These products are sold through the company's website, affiliate marketing programs, and wholesale distribution channels.
What do analysts say about MCOA stock?
As of 2026-03-17, there is no available analyst coverage for Marijuana Company of America, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-0.09), profit margin (-1441.1%), and gross margin (-74.1%) indicate significant financial challenges. Potential investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC-listed companies with limited financial information.
What are the main risks for MCOA?
The main risks for Marijuana Company of America, Inc. include intense competition in the cannabis and CBD market, complex and evolving regulations, fluctuations in consumer demand, and potential product recalls. The company's negative profitability and gross margins pose a significant threat to its financial sustainability. Additionally, its OTC listing and limited financial disclosure increase the risk of fraud or manipulation. Investors should carefully consider these risks before investing in MCOA.
What are the key factors to evaluate for MCOA?
Marijuana Company of America, Inc. (MCOA) holds an AI score of 42/100 (low). Investing in Marijuana Company of America, Inc. Not financial advice.
How frequently does MCOA data refresh on this page?
MCOA's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MCOA's recent stock price performance?
Marijuana Company of America, Inc. (MCOA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established hempSMART brand. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MCOA overvalued or undervalued right now?
Marijuana Company of America, Inc. (MCOA) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MCOA before investing?
Before investing in Marijuana Company of America, Inc. (MCOA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data may not be fully reliable.
- AI analysis pending.